|Bid||51.85 x 1800|
|Ask||52.00 x 900|
|Day's Range||51.94 - 52.03|
|52 Week Range||25.02 - 52.10|
|Beta (3Y Monthly)||2.11|
|PE Ratio (TTM)||23.74|
|Earnings Date||Feb 12, 2018 - Feb 16, 2018|
|Forward Dividend & Yield||0.32 (0.65%)|
|1y Target Est||49.40|
NOTE: On April 17, 2019, the press release was corrected as follows: In the third sentence, the description of the affirmed rating was changed to short term issuer rating. Revised release follows. Paris, April 16, 2019 -- Moody's Investors Service, ("Moody's") has today affirmed Merck KGaA's ('Merck') issuer rating, senior unsecured Medium Term Note and subordinated ratings at Baa1, (P)Baa1 and Baa3 respectively.
The companies have inked their definitive merger agreement, and regulatory filings show that several more Versum executives will be eligible to receive hefty bonuses after the deal is consummated.
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating whether the sale of Versum Materials, Inc. (“Versum” or the “Company”) (VSM) to Merck KGaA (“Merck”) is fair to Versum shareholders. If you are a Versum shareholder and would like to discuss your legal rights and options, please visit Versum (VSM) Merger Investigation or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or firstname.lastname@example.org or email@example.com.
NEW YORK, NY / ACCESSWIRE / April 15, 2019 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Versum Materials, Inc. ("Versum" or the ...
The business combination received unanimous approval from the boards of the German pharmaceutical company and Versum, Merck said in a Friday press release. Versum is a supplier of process chemicals, gases and semiconductor manufacturing equipment.
Germany's Merck KGaA sealed a $6.5 billion (4.9 billion pounds) takeover deal with Versum Materials after overturning a deal it had agreed with rival bidder Entegris. A bet on a recovery in electronic materials markets for semiconductor makers, the transaction will boost the share of profit that diversified Merck derives from high-tech chemicals to 27 percent from 19 percent previously. Merck, also maker of pharmaceuticals and biotech production gear, this week won the backing of Versum's board for its $53-per-share offer, lifted from $48 previously, having been spurned for weeks.
Merck KGaA said Friday it has signed a definitive agreement to acquire Versum Materials Inc. in a deal with an enterprise value of 5.8 billion euros ($6.6 billion). Merck will pay $53 per Versum share in cash to create a top supplier of high-purity process chemicals, gases and equipment for semiconductor manufacturing, the company said in a statement. The deal is expected to immediately boost Merck's per-share earnings and to close in the second half. Versum's board has terminated its merger agreement with Entegris Inc. on the grounds that the Merck offer is superior. The deal will be financed with cash on hand and debt via a facilities agreement with Bank of America Merrill Lynch, BNP Paribas Fortis and Deutsche Bank AG. Merck is determined to maintain its strong investment grade rating, it said in a statement. Versum shares were slightly higher premarket, but have gained 38% in the past 12 months, while the S&P 500 has gained 8%.
Merck KGaA, Darmstadt, Germany, a leading science and technology company, has signed a definitive agreement to acquire Versum Materials, Inc. (VSM) for $53 per share in cash. The business combination has been unanimously approved by the Executive Board of Merck KGaA, Darmstadt, Germany and by Versum’s Board of Directors.
After last-minute whirlwind trans-Atlantic negotiations, Tempe's Versum Materials Inc. has said it wants to pull out of a deal to merge with a U.S. company in order to be acquired by a much larger German corporation.
Announcement: Moody's says revised proposal from Merck KGaA is credit positive for Versum. Global Credit Research- 09 Apr 2019. New York, April 09, 2019-- Moody's Investors Service commented on the announcement ...
Versum Materials Inc NYSE:VSMView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is extremely low for VSM with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting VSM. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding VSM are favorable with net inflows of $71.21 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managersâ€™ Index (PMI) data, output in the Basic Materialsis falling. The rate of decline is significant relative to the trend shown over the past year. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Versum Materials, Inc . (NYSE: VSM ) announced Monday that it received a revised proposal from Merck KGaA to acquire Versum for $53 per share, up from Merck's prior $48-per-share proposal on Feb. 27. ...
Merck KGaA won the backing of Versum's board for a sweetened $6.5 billion (4.98 billion pounds) takeover proposal, overturning an agreed merger with rival Entegris as it bets on a recovery in electronic materials markets. "This proposal constitutes a 'Superior Proposal' as defined in Versum's previously announced merger agreement with Entegris, Inc.," Versum said in a statement on Monday. On a per share basis, Germany's Merck offered $53, up from $48 previously, after reviewing business data and following meetings between Merck Chief Executive Stefan Oschmann and Versum Chairman Seifi Ghasemi, filings showed.
Entegris has considered its options and does not currently intend to propose to revise the terms of the Entegris-Versum merger of equals. Entegris is a leader in specialty chemicals and advanced materials solutions for the microelectronics industry and other high-tech industries. Entegris is ISO 9001 certified and has manufacturing, customer service and/or research facilities in the United States, China, France, Germany, Israel, Japan, Malaysia, Singapore, South Korea and Taiwan.
Versum Materials, Inc. (VSM) today announced that it has received a revised proposal from Merck KGaA, Darmstadt, Germany (“Merck”) to acquire Versum for $53 per share, and that Versum’s Board of Directors, in consultation with its legal and financial advisors, has unanimously determined that this proposal constitutes a “Superior Proposal” as defined in Versum’s previously announced merger agreement with Entegris, Inc. (ENTG). Under the terms of Merck’s revised proposal, Merck would acquire all of the outstanding shares of common stock of Versum for $53 per share in cash, an increase from the previously announced $48 per share proposal made by Merck on February 27, 2019.
NEW YORK, NY / ACCESSWIRE / April 6, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire StateBuilding in New York ...
Versum Materials, Inc. (VSM) today announced the filing of an investor presentation with the Securities and Exchange Commission (SEC), and that the Versum Board of Directors sent a letter to Versum shareholders regarding the previously announced definitive merger agreement with Entegris, Inc. (ENTG), urging shareholders to vote the WHITE proxy card “FOR” the merger agreement with Entegris at the Special Meeting of Stockholders on April 26, 2019.
Though Versum has said its board rejects a hostile takeover bid by Merck KGaA, company officials are continuing negotiations with the German suitor.
"Merck’s proposal could reasonably be expected to result in a superior proposal," Versum, a maker of chemicals for the semiconductor industry, cited its board as saying in a statement on Friday. The board "has authorized Versum's management and its advisers to engage in further discussions with, and provide non-public information to, Merck," the statement added.
Entegris, Inc. (ENTG), a leader in specialty chemicals and advanced materials solutions for the microelectronics industry, today commented on Versum Materials’ (VSM) (“Versum”) announcement that it has rejected Merck KGaA’s (“Merck”) unsolicited tender offer to acquire all outstanding shares of Versum for $48 per share in cash and that the Versum Board of Directors continues to recommend the previously announced proposed merger-of-equals between Versum and Entegris.
FRANKFURT (Reuters) - Merck KGaA on Friday welcomed Versum Materials to the negotiation table after the takeover target said it was willing to hold talks over Merck's unsolicited offer. "We welcome ...
Versum Materials, Inc. (VSM) today announced that its board of directors (the “Versum Board”), after careful consideration and consultation with its financial and legal advisors, unanimously determined to reject the unsolicited tender offer from Merck KGaA (“Merck”) to acquire all outstanding shares of Versum for $48 per share in cash (the “Offer”). The Versum Board determined that the Offer is not in the best interests of Versum or its stockholders. Accordingly, the Versum Board recommends that Versum stockholders reject the Offer and not tender their shares into the Offer.
Versum announced in January it planned to merge with Entegris Inc. in a deal that would move the company’s headquarters out of Tempe into Entegris’ offices in Massachusetts.
German pharma group Merck KGaA launched a hostile $5.9 billion (£4.5 billion) all-cash takeover offer for Versum Materials on Tuesday to boost its presence in the semiconductor materials market and sideline a rival bidder. Versum, the former speciality chemicals division of industrial gases group Air Products, has been opposed to Merck's unsolicited cash offer since it was first proposed last month, saying it was committed to an all-share merger with U.S. rival Entegris agreed in January. Merck kept its offer price unchanged at $48 per share on Tuesday.